Pigmented Paravenous Chorioretinal Atrophy: Clinical Spectrum and Multimodal Imaging Characteristics.
Lee Eun Kyoung, Lee Sang-Yoon, Oh Baek-Lok, Yoon Chang Ki, Park Un Chul, Yu Hyeong Gon
AI Summary
PPCRA shows variable clinical presentations and progression, with multimodal imaging crucial for diagnosis, classification, and monitoring, as some cases involve severe vision loss.
Abstract
Purpose
To investigate the clinical findings and natural course of patients with pigmented paravenous chorioretinal atrophy (PPCRA) using multimodal imaging.
Design
Retrospective, observational case series.
Methods
We reviewed the records of consecutive patients diagnosed with PPCRA at a single center and assessed serial fundus photographs, fundus autofluorescence (FAF), and spectral-domain optical coherence tomography images. Electrophysiological findings and visual field analysis were also reviewed.
Results
The study included 50 eyes in 25 patients. The mean age of the population was 51.6 ± 14.6 years. Nine patients (36.0%) were asymptomatic and 9 (36.0%) complained of nyctalopia. We divided fundus appearance into one of 3 groups: paravenous (58.0%), focal (16.0%), and confluent (26.0%). Of the 50 eyes, macular involvement was present in 13 eyes (26.0%). Fifteen patients (60.0%) demonstrated a symmetric fundus appearance, whereas 10 (40.0%) had marked asymmetry. Eight eyes (16.0%) exhibited apparent changes in fundus findings, over a mean follow-up period of 8.8 years. FAF imaging was most sensitive to evaluate the extent of lesions. Sixteen eyes (44.4%) showed progressive visual field loss during the follow-up period. Most patients maintained stable vision, and 36 eyes (72.0%) had a final visual acuity of 20/50 or better. Nevertheless, some eyes with macular involvement experienced severe deterioration in vision. Electrophysiological data were variable, and interocular asymmetry was common (45.8%).
Conclusions
PPCRA can present with a more variable expressivity than previously described. Multimodal imaging can provide insights into its clinical characteristics to facilitate the diagnosis, classification, and follow-up of these patients.
MeSH Terms
Shields Classification
Key Concepts6
In a retrospective, observational case series of 50 eyes in 25 patients with pigmented paravenous chorioretinal atrophy (PPCRA), 9 patients (36.0%) were asymptomatic.
In a retrospective, observational case series of 50 eyes in 25 patients with pigmented paravenous chorioretinal atrophy (PPCRA), 9 patients (36.0%) complained of nyctalopia.
In a retrospective, observational case series of 50 eyes in 25 patients with pigmented paravenous chorioretinal atrophy (PPCRA), fundus appearance was categorized into paravenous (58.0%), focal (16.0%), and confluent (26.0%) types.
In a retrospective, observational case series of 50 eyes in 25 patients with pigmented paravenous chorioretinal atrophy (PPCRA), macular involvement was present in 13 eyes (26.0%).
In a retrospective, observational case series of 50 eyes in 25 patients with pigmented paravenous chorioretinal atrophy (PPCRA) and a mean follow-up period of 8.8 years, 16 eyes (44.4%) showed progressive visual field loss.
In a retrospective, observational case series of 50 eyes in 25 patients with pigmented paravenous chorioretinal atrophy (PPCRA), fundus autofluorescence (FAF) imaging was most sensitive to evaluate the extent of lesions.
Related Articles5
Extensive Macular Atrophy with Pseudodrusen-like appearance: Progression Kinetics and Late-Stage Findings.
Cohort StudyRelationship between outer retinal tubulation, retinal volume, and visual field in Bietti crystalline dystrophy.
Cross-Sectional StudyRisk of newly developing visual field defect and neurodegeneration after pars plana vitrectomy for idiopathic epiretinal membrane.
Cohort StudyElectroretinogram and Visual Field Correlation in Birdshot Chorioretinopathy.
Cross-Sectional StudyAqueous Flare and Progression of Visual Field Loss in Patients With Retinitis Pigmentosa.
Cohort StudyIs this article assigned to the wrong chapter(s)? Let us know.